Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 항체 > 중화 항체

InVivoMAb Anti-Mouse IL-17A Antibody (17F3) (MS856020)

InVivoMAb Anti-Mouse IL-17A Antibody (17F3)
InVivoMAb Anti-Mouse IL-17A Antibody (17F3)
가격(USD):
사양:
  • 100ug
  • 1mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호MS856020
설명
InVivoMAb Anti-Mouse IL17A Antibody (17F3) [17F3] (MS856020) is a mouse monoclonal antibody detecting CTLA-8 in ELISA, Neutralization. Suitable for Mouse.
종 반응성Mouse
응용 분야ELISA, Neutralization
숙주 종Mouse
클론성Monoclonal
이소타입IgG1, kappa
클론 ID17F3
타겟 CTLA-8, CTLA8, Cytotoxic T-lymphocyte-associated antigen 8, IL-17, IL-17A, IL17, IL17A, Interleukin-17A
내독소 수준 < 1 EU/mg
순도 >95% as determined by SDS-PAGE.
관련 제품 pH 7.4 Dilution Buffer
정제 Protein A/G purified from cell culture supernatant.
등록번호 Q62386
형태 Liquid
저장 완충액 0.01M PBS pH 7.4.

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

제품 사용 정보
응용 분야 희석
ELISA 1:2000-1:20000
안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
배경

Interleukin-17A (IL17A) is a ~17 kDa protein. Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation. Plays an important role in connecting T cell-mediated adaptive immunity and acute inflammatory response to destroy extracellular bacteria and fungi. As a signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites. IL17A is the therapeutic target of secukinumab (Cosentyx).

1. Liang, SC. et al. (2007) Journal of immunology (Baltimore, Md. : 1950) 179, 7791-9. PMID: 18025225
2. Ishigame, H. et al. (2009) Immunity 30, 108-19. PMID: 19144317
3. Lee, JS. et al. (2015) Immunity 43, 727-38. PMID: 26431948
4. Park, H. et al. (2005) Nature immunology 6, 1133-41. PMID: 16200068
5. Kuestner, RE. et al. (2007) Journal of immunology (Baltimore, Md. : 1950) 179, 5462-73. PMID: 17911633
6. Chen, K. et al. (2016) Cell host & microbe 20, 596-605. PMID: 27923703
참고사항 For research use only. Not suitable for clinical or therapeutic use.
이미지
  • InVivoMAb Anti-Mouse IL-17A Antibody (17F3)

    SDS-PAGE

    SDS-PAGE for InVivoMAb Anti-Mouse IL17A Antibody (17F3)

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록